Q2 2021 13F Holders as of 30 Jun 2021
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
104,986,330
-
Total 13F shares
-
79,727,291
-
Share change
-
-103,638
-
Total reported value
-
$44,477,094,257
-
Put/Call ratio
-
128%
-
Price per share
-
$558.54
-
Number of holders
-
947
-
Value change
-
-$28,924,360
-
Number of buys
-
496
-
Number of sells
-
380
Institutional Holders of REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) as of Q2 2021
As of 30 Jun 2021 REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) had 947 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 79,727,291 shares of stock of the company.
Largest 10 holders included FMR LLC, VANGUARD GROUP INC, Capital World Investors, STATE STREET CORP, WELLINGTON MANAGEMENT GROUP LLP, JPMORGAN CHASE & CO, LOOMIS SAYLES & CO L P, GEODE CAPITAL MANAGEMENT, LLC, HARRIS ASSOCIATES L P, and Capital International Investors.
This table shows 958 institutional shareholders of the security as of 30 Jun 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.